Literature DB >> 28877383

Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.

Sven Heldt1,2, Susanne Eigl1, Juergen Prattes2,3, Holger Flick1, Jasmin Rabensteiner4, Florian Prüller4, Tobias Niedrist4, Peter Neumeister5, Albert Wölfler3,5, Heimo Strohmaier6, Robert Krause2,3, Martin Hoenigl1,2,3,7.   

Abstract

Aspergillus spp. have been shown to induce T-helper cell (Th) 1 and Th17 subsets resulting in elevated levels of several cytokines. The objective of this study was to analyse a bundle of cytokines in serum and bronchoalveolar lavage fluid (BALF) in patients with and without invasive pulmonary aspergillosis (IPA). This nested case-control analysis included 10 patients with probable/proven IPA and 20 matched controls without evidence of IPA, out of a pool of prospectively enrolled (2014-2017) adult cases with underlying haematological malignancies and suspected pulmonary infection. Serum samples were collected within 24 hours of BALF sampling. All samples were stored at -70°C for retrospective determination of cytokines. IL-6 and IL-8 were significantly associated with IPA in both serum (P = .011 and P = .028) and BALF (P = .006 and P = .012, respectively), and a trend was observed for serum IL-10 (P = .059). In multivariate conditional logistic regression analysis, IL-10 remained a significant predictor of IPA in serum and IL-8 among BALF cytokines. In conclusion, levels of IL-6 and IL-8 were significantly associated with probable/proven IPA, and a similar trend was observed for serum IL-10. Future cohort studies should determine the diagnostic potential of these cytokines for IPA, and evaluate combinations with other IPA biomarkers/diagnostic tests.
© 2017 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Aspergilluszzm321990; BAL; IFN-γ; IL-10; IL-17A; haematological malignancy; serum

Mesh:

Substances:

Year:  2017        PMID: 28877383     DOI: 10.1111/myc.12679

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  19 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Video-assisted thoracoscopic surgery for invasive pulmonary fungal infection in haematology patients.

Authors:  Han Ma; Jun Wang; Xiao Ma; Shiying Zheng; Haitao Ma; Jinfeng Ge
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

3.  Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.

Authors:  Sven Heldt; Juergen Prattes; Susanne Eigl; Birgit Spiess; Holger Flick; Jasmin Rabensteiner; Gemma Johnson; Florian Prüller; Albert Wölfler; Tobias Niedrist; Tobias Boch; Peter Neumeister; Heimo Strohmaier; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  J Infect       Date:  2018-07-01       Impact factor: 6.072

4.  Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.

Authors:  Martin Hoenigl; Thomas Orasch; Klaus Faserl; Juergen Prattes; Juergen Loeffler; Jan Springer; Fabio Gsaller; Frederike Reischies; Wiebke Duettmann; Reinhard B Raggam; Herbert Lindner; Hubertus Haas
Journal:  J Infect       Date:  2018-09-26       Impact factor: 6.072

5.  Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients.

Authors:  Samuel M Gonçalves; Katrien Lagrou; Cláudia S Rodrigues; Cláudia F Campos; Leticia Bernal-Martínez; Fernando Rodrigues; Ricardo Silvestre; Laura Alcazar-Fuoli; Johan A Maertens; Cristina Cunha; Agostinho Carvalho
Journal:  Front Microbiol       Date:  2017-11-29       Impact factor: 5.640

6.  The changes of expressive levels of IL-17A, STAT3, and RORγt in different invasive pulmonary aspergillosis mice.

Authors:  Lingna N Xu; Ren-Ai Xu; Dan Zhang; Shanshan S Su; Hanyan Y Xu; Qing Wu; Yuping P Li
Journal:  Infect Drug Resist       Date:  2018-08-27       Impact factor: 4.003

Review 7.  Pathogenic Fungal Infection in the Lung.

Authors:  Zhi Li; Gen Lu; Guangxun Meng
Journal:  Front Immunol       Date:  2019-07-03       Impact factor: 7.561

Review 8.  Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Authors:  Jeffrey D Jenks; Helmut Jf Salzer; Juergen Prattes; Robert Krause; Dieter Buchheidt; Martin Hoenigl
Journal:  Drug Des Devel Ther       Date:  2018-04-30       Impact factor: 4.162

9.  Impact of ITS-Based Sequencing on Antifungal Treatment of Patients with Suspected Invasive Fungal Infections.

Authors:  Sara Guenter; Gregor Gorkiewicz; Bettina Halwachs; Karl Kashofer; Andrea Thueringer; Phillip Wurm; Ines Zollner-Schwetz; Thomas Valentin; Juergen Prattes; Stefanie Wunsch; Elisabeth Ullrich; Christoph Zurl; Martin Hoenigl; Robert Krause
Journal:  J Fungi (Basel)       Date:  2020-03-27

10.  Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Helmut J F Salzer; Juergen Prattes; Holger Flick; Maja Reimann; Jan Heyckendorf; Barbara Kalsdorf; Sabrina Obersteiner; Karoline I Gaede; Christian Herzmann; Gemma L Johnson; Christoph Lange; Martin Hoenigl
Journal:  Front Microbiol       Date:  2018-10-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.